Key result
High social deprivation index links to a greater proportion of Black and Hispanic cancer patients.
Why the study?
Healthcare access and representation can vary significantly by race, ethnicity, and neighborhood deprivation, prompting investigation of the association between the social deprivation index and race/ethnicity across common US cancer types.
Cross-Sectional (n=245,767)
Answers are grounded in this paper and cite their sources.
Location-based disadvantage is highly racialized and ethnicized across common cancers, which may represent barriers to precision oncology access and bias genomic evidence.
e23429 Background: Healthcare access and representation can vary significantly by race, ethnicity and neighborhood deprivation. SDI calculation incorporates factors like poverty, education, employment, housing, transportation and family structure associated with residential zip codes. Here we investigated the association between SDI and race/ethnicity for the most common cancer types in the US. Methods: Patients with Bladder (n = 11,148), Breast (n = 34,285), Colorectal (CRC, n = 48,998), Endometrial (EMCA, n = 26,290), Kidney (n = 5,991), Non-small cell lung cancer (NSCLC, n = 72,397), Melanoma (n = 11044), Pancreatic (n = 19,444) and Prostate (n = 16,170) cancers were included from Caris Life Sciences (Phoenix, AZ) with NGS (NGS-592, WES) sequencing. Race and ethnicity was self-reported. Genetic ancestry (GA) was inferred by 36,962 ancestry-informative variants derived from globally diverse Genome Aggregation Database (gnomAD) reference individuals (n = 4,150). 3-digit residential zipcodes were extracted and paired with publicly available SDI (US Census Bureau). Prevalences were calculated across SDI quartiles (Q1-4). Significance was calculated by chi-square with Benjamini-Hochberg corrections. Results: Across all cancer types SDI Q4 was associated with a greater proportion (%) of Black/African American (BAA) and Hispanic or Latino (H/L) patients (all q < 0.001). When incorporating genetic ancestry data, there was also a greater proportion of patients with African (AFR) ancestry and Indigenous Americans (AMR) ancestry with increased SDI quartile (Q4 vs Q1 q < 0.001) (Table 1). Conclusions: Location-based disadvantage is racialized/ethnicized across cancers as B/AA, H/L patients and those with AFR and AMR ancestry are disproportionately more populated in high deprivation neighborhoods (SDI Q4). This disparity may represent barriers to precision oncology access and can severely bias genomic evidence and should be accounted for in translational research. Proportion of each racial/ethnic characteristic by SDI Quartile by cancer. (Q-values compare Q1 vs Q4, all q<0.001. Headers annotated as "Characteristic: SDI Quartile".). Cancer BAA: Q1% BAA: Q2% BAA: Q3% BAA: Q4% H/L: Q1% H/L: Q2% H/L: Q3% H/L: Q4% AFR: Q1% AFR: Q2% AFR: Q3% AFR: Q4% AMR: Q1% AMR: Q2% AMR: Q3% AMR: Q4% Bladder 13 20 25 42 11 17 19 52 13 21 26 40 12 18 23 47 Breast 15 19 23 43 13 17 25 45 15 20 24 40 13 17 29 42 CRC 13 20
No takes yet. Share an insight, caveat, or question.
Puri et al. (2026) conducted a cross-sectional in Cancer (n=245,767). High social deprivation index (SDI Quartile 4) vs. Low social deprivation index (SDI Quartile 1) was evaluated on Proportion of racial/ethnic minority and genetic ancestry groups across SDI quartiles (p=<0.001). High social deprivation index (SDI Q4) was associated with a greater proportion of Black/African American and Hispanic/Latino cancer patients compared to lower quartiles.
Synapse has enriched 10 related papers. Consider them for comparative context: